| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $476,244 ) |
| 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114 | SUFFOLK | USA | Cancer Treatment Research | 000 | 5 | 4/30/2025 | NON-COMPETING CONTINUATION | $476,244 |
|
 | Issue Date FY: 2024 ( Subtotal = $505,171 ) |
| 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114 | SUFFOLK | USA | Cancer Treatment Research | 000 | 4 | 4/5/2024 | NON-COMPETING CONTINUATION | $505,171 |
|
 | Issue Date FY: 2023 ( Subtotal = $521,122 ) |
| 2023 | 2023 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114 | SUFFOLK | USA | Cancer Treatment Research | 000 | 3 | 5/1/2023 | NON-COMPETING CONTINUATION | $521,122 |
|
 | Issue Date FY: 2022 ( Subtotal = $527,406 ) |
| 2022 | 2022 | MASSACHUSETTS GENERAL HOSPITAL, THE | 55 FRUIT ST | BOSTON | MA | 02114 | SUFFOLK | USA | Cancer Treatment Research | 000 | 2 | 5/23/2022 | NON-COMPETING CONTINUATION | $527,406 |
|
 | Issue Date FY: 2021 ( Subtotal = $562,821 ) |
| 2021 | 2021 | MASSACHUSETTS GENERAL HOSPITAL, THE | 55 FRUIT ST | BOSTON | MA | 02114 | SUFFOLK | USA | Cancer Treatment Research | 000 | 1 | 4/26/2021 | NEW | $562,821 |
|
|